ÂÜÀòÂÒÂ×

Dan Szeliga is an experienced executive in the biopharmaceutical industry, currently serving as the Senior Vice President and Head of Commercial and Business Operations at RayzeBio. Previously, Szeliga held the position of Vice President of Worldwide Commercial Portfolio Planning at Mirati Therapeutics and was Vice President of the US Oncology Thoracic & GI Franchise Lead at Bristol-Myers Squibb. Additional experience includes roles such as Executive Director for Opdivo in lung cancer and Brand Lead for Erbitux in US oncology marketing at Bristol-Myers Squibb, as well as Global Brand Director for Oncology at Abraxis Oncology and Brand Marketing Manager for Taxotere at Sanofi / Aventis Oncology.